首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1700312

客自訂檢測開發市場報告：2031 年趨勢、預測與競爭分析

Custom Assay Development Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年04月07日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球自訂檢測開發市場前景廣闊，在醫療、生物、環境和學術市場都存在機會。預計全球自訂檢測開發市場從 2025 年到 2031 年的複合年成長率為 7.7%。該市場的主要驅動力是對個人化醫療和標靶治療日益成長的需求，以及正在進行的生物標記發現和檢驗。

Lucintel 預測，在預測期內，檢測開發將經歷按類型分類的最高成長率。
從應用角度來看，醫療保健預計將實現最高成長。
根據地區，預計北美將在預測期內實現最高成長。

客自訂檢測開發市場的策略性成長機會

客自訂分析開發市場中的廣泛應用提供了多種策略成長機會，這主要歸功於技術進步和新興市場不斷變化的醫療需求。

基因組學和蛋白質組學檢測：各種研究和臨床領域對自訂基因組學和蛋白質組學檢測的需求日益成長。能夠分析複雜生物樣本的檢測方法的開發將提高我們對疾病機制的理解並促進個人化治療。
感染疾病診斷：高感染疾病負擔需要開發快速診斷測試和自訂檢測系統。關注感染疾病診斷有利於許多衛生系統的公共衛生和個別患者。
藥物成果：對個人化醫療的重視正在推動伴隨診斷的潛在成長。這些專門的檢測有助於確定患者對特定治療的反應，有助於制定更好的治療計劃並提高治療效果。
環境檢測：自訂檢測市場正隨著環境測試的趨勢而多樣化，其中經皮和血液檢測用於檢測毒素和病原體。透過此類檢測解決污染問題有助於促進公眾健康和遵守衛生法規。
PoC 偵測：對各種即時診斷 (PoC) 解決方案的需求日益成長，推動了對客自訂PoC 偵測的需求。提供簡單、經濟高效的照護現場替代方案可以減少患者在及時接受檢測時的不適感，並提高醫療服務的品質。

這些成長機會代表著自訂檢測服務市場的顯著擴張。利用這些應用程式將使相關人員能夠推動創新並增強各個領域的診斷能力。

自訂檢測開發市場促進因素與挑戰

客自訂檢測開發市場受到多種動態因素的影響，包括技術、經濟和監管，這些因素為相關人員帶來了機會和挑戰。

推動客自訂檢測開發市場的因素有：

技術發展：不斷推出新產品，尤其是具有工業自動化和連接複用的檢測技術，對市場成長做出了重大貢獻。這些進步將提高檢測的有效性並改善其診斷和研究用途。
對標靶治療系統的需求不斷增加：向以患者為中心的醫療保健的轉變正在支持對特定自訂檢測服務的需求。這項發展將實現更好、更有針對性的治療方法，改善患者的治療效果並促進市場成長。
增加研發支出：增加研發投資，特別是在生物技術和醫療保健領域的投資，正在推動自訂檢測市場的發展。這樣的資助可以促進創造力並鼓勵創造更好、更快的檢測方法。
支持性政策：擴大監管規定使得自訂偵測的核准流程變得更加容易。鼓勵研究和診斷相關人員實施概念，促進新診斷方法快速進入市場。
全球健康計劃：改善全球健康的努力正在推動對準確、及時診斷的需求。客自訂檢測是一個不斷成長的市場，因為它們在改善公共衛生方面發揮關鍵作用。

客製自訂檢測開發市場面臨的挑戰包括：

開發成本高：開發客製自訂檢測方法的成本可能很高，尤其是對於中小型公司而言。此類經濟壁壘可能會限制新技術的好處，並限制一些公司進入市場。
複雜的監管環境：檢測開發過程通常因監管要求而變得複雜。一些地區的法規嚴格而複雜，可能會延長產品上市的時間。
市場競爭：客自訂檢測服務市場高度分散，各公司都在爭取市場佔有率。這種競爭推高了成本，需要尖端研究來保持競爭力。

摘要：自訂檢測開發市場正受到這些市場促進因素和挑戰的共同驅動和影響。對於相關人員來說，制定策略來利用機會並減少障礙以在這種競爭環境中前進至關重要。

宏觀經濟趨勢（2019-2024）及預測（2025-2031）
全球自訂檢測開發市場趨勢（2019-2024）及預測（2025-2031）
全球自訂檢測開發市場（按類型）
- 檢測方法開發
- 檢測最佳化
- 測定轉化
- 新分析物的開發
- 自訂聯軸器
- 自訂使用
- 樣品測試
- 其他
全球自訂檢測開發市場（按應用）
- 醫療保健
- 生物學
- 環境
- 學術的
- 其他

第4章區域市場趨勢與預測分析（2019-2031）

全球自訂檢測開發市場（按地區）
北美客自訂檢測開發市場
歐洲自訂檢測開發市場
亞太地區自訂檢測開發市場
世界其他地區自訂檢測開發市場

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球自訂檢測開發市場成長機會（按類型）
- 全球客自訂檢測開發市場的成長機會（按應用）
- 全球自訂檢測開發市場各區域成長機會
全球自訂檢測開發市場的新趨勢
戰略分析
- 新產品開發
- 全球客自訂檢測開發市場的產能擴張
- 全球自訂檢測開發市場的企業合併
- 認證和許可

第7章主要企業簡介

2BScientific
PerkinElmer
Eurofins Discovery
Thermos Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate

簡介目錄

The future of the global custom assay development market looks promising, with opportunities in the medicine, biology, environment, and academic markets. The global custom assay development market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and targeted therapies and ongoing advancement in biomarker discovery and validation.

Lucintel forecasts that, within the type category, assay development is expected to witness the highest growth over the forecast period.
Within the application category, medicine is expected to witness the highest growth.
In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Custom Assay Development Market

The custom assay development market is expanding while undergoing many changes due to the emergence of several trends. These trends reveal the market positioning and potential areas for development.

Personalized Medicines Offer New Opportunities for Diagnostic Companies: The growth of personalized medicine is increasing the need for custom assays tailored to individual patient profiles. This situation attracts more complex diagnostics and therapies, which benefits patients and contributes to the overall progress of healthcare interventions.
Addition of Artificial Intelligence and Automation: The use of artificial intelligence and simultaneous automation in the development of assays is increasing effectiveness and accuracy. These technologies optimize the design phase, minimize errors, and expedite the development of complex assays for new diagnostics.
Growth of Multiplex Assays: Multiplex assays are transforming the market by enabling the simultaneous detection of several targets, thereby increasing the scope of diagnostics. This trend improves testing efficiency and conserves resources, which is advantageous in both clinical and research settings.
Initiatives to Streamline Approvals for Custom Assays: More countries are adopting new regulations that simplify the approval process for custom assays, making standards more comprehensible for developers. This encouragement fosters new ideas and financial support for developing new assays, aiding market growth.
Rising Significance of Point-of-Care Testing: The increasing demand for diagnostic procedures in doctors' offices or laboratories is driving advancements in custom assays. Innovations allow for timely diagnostics, enhancing the dynamics of change in a medically oriented healthcare system and promoting decentralization.

Such trends are being integrated into the custom assay development market to foster innovation, enhance efficiency, and, most importantly, provide personalized healthcare solutions.

Recent Developments in the Custom Assay Development Market

There have also been substantive developments in the custom assay development market stemming from technological advancements and strategic initiatives to improve testing accuracy and applicability.

Advanced Multiplexing Technologies: Advanced multiplexing technologies enable the use of the same assay for the simultaneous measurement of various biomarkers. This marks a significant step towards improving research, clinical diagnostics, and decision-making, particularly in patient management.
AI-Driven Assay Design: The assay design process is undergoing a revolution, largely due to the role of artificial intelligence. Understanding and simulating optimal assay conditions are part of AI algorithms that facilitate a more efficient test development process, allowing for quick dispensing of necessary test results in the medical field.
Collaboration Initiatives: Partnerships and collaborations between biotech companies and research institutions are on the rise, helping to drive innovation in the study and development of assays. Such collaborations enhance resource sharing and aid in developing advanced assays that bring research closer to practical application.
Growth in Emerging Countries: The development of custom assay services is rapidly expanding in less developed regions, especially in Asia. Local players are providing relevant and affordable products, increasing the market for diagnostics.
Regulatory Improvements: New structured guidelines are opening doors for easier approval of custom assays. This development attracts relevant stakeholders to the field, promoting the creation of new strategies for assays.

These developments are changing the landscape of custom assay development by improving the quality and efficiency of testing solutions, ultimately leading to better healthcare systems.

Strategic Growth Opportunities for Custom Assay Development Market

A wide array of applications in the custom assay development market presents several strategic growth opportunities, primarily due to technological advancements and evolving healthcare demands.

Assays for Genomics and Proteomics: There is a growing need for custom-made genomic and proteomic assays across various research and clinical areas. Creating assays that can profile complex biological samples will enhance the understanding of disease mechanisms and facilitate personalized therapies.
Diagnosing Infectious Diseases: The high burden of infectious diseases necessitates the development of rapid diagnostic testing and custom-assayed systems. Focusing on infectious disease diagnostics benefits public health and individual patients in many healthcare systems.
Pharmaceutical Outcomes: The emphasis on personalized medicine is driving growth potential for companion diagnostics. These specialized assays help determine how a patient will respond to specific therapies, aiding in better planning and effectiveness of treatments.
Environmental Assays: The custom assay market is diversifying with the trend of environmental testing, where dermal and blood assays are used to detect toxins and pathogens. Addressing pollution through these assays promotes public health and compliance with health legislation.
Point-of-Care Assays: The demand for point-of-care custom assays is rising due to the increasing need for extensive point-of-care solutions. Providing simple and cost-effective point-of-care alternatives will reduce patients' discomfort in accessing timely tests and improve healthcare service quality.

These growth opportunities indicate that the custom assay services market will expand significantly. By leveraging these applications, stakeholders can foster innovation and enhance diagnostics across various fields.

Custom Assay Development Market Driver and Challenges

The custom assay development market is influenced by several dynamic factors, including technological, economic, and regulatory aspects, which present both opportunities and challenges for stakeholders.

The factors driving the custom assay development market include:

Technology Development: The continuous introduction of new products, especially assay technologies featuring industrial automation and multiplexing, has significantly contributed to market growth. These advancements enhance assay effectiveness and improve the quality of diagnostics and research utilization.
Increase in Demand for Targeted Therapeutic Systems: The shift toward patient-centered care sustains the demand for specific custom assay services. This development enables better and more targeted treatment approaches, resulting in improved patient outcomes and market growth.
Expansion of R&D Spending: Increased investment in research and development, particularly in biotechnology and healthcare, is boosting the custom assay market. This funding fosters creativity and the creation of better and faster assays.
Supporting Policies: Widening regulatory provisions are making the approval process for custom assays increasingly straightforward. Stakeholders in research and diagnostics are encouraged to implement their concepts, facilitating quicker market entry for new diagnostics.
Global Health Initiatives: Efforts to improve global health are increasing the demand for accurate and timely diagnostics. Custom assays play a crucial role in enhancing public health, thus expanding the market scope.

Challenges in the custom assay development market include:

Unaffordable Development Costs: Developing custom assays can be particularly expensive for small and medium enterprises. These financial barriers may limit the advantages of new technologies and restrict market entry for some companies.
Complex Regulatory Landscape: The process of developing assays can be cumbersome due to regulatory requirements. Stringent and convoluted rules in some regions can lengthen the time to market for products.
Market Competition: The custom assay service market is highly fragmented, with various players competing for market share. This competition drives costs and necessitates up-to-date research to maintain a competitive edge.

In summary, the custom assay development market is driven and shaped by a combination of these drivers and challenges. It is crucial for stakeholders to devise strategies that capitalize on opportunities and minimize obstacles to advance in this competitive landscape.

List of Custom Assay Development Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, custom assay development companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the custom assay development companies profiled in this report include-

2BScientific
PerkinElmer
Eurofins Discovery
Thermos Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate

Custom Assay Development by Segment

The study includes a forecast for the global custom assay development market by type, application, and region.

Custom Assay Development Market by Type [Analysis by Value from 2019 to 2031]:

Assay Development
Assay Optimization
Assay Conversion
New Analyte Development
Custom Coupling
Custom Conjugation
Sample Testing
Others

Custom Assay Development Market by Application [Analysis by Value from 2019 to 2031]:

Medicine
Biology
Environment
Academic
Others

Custom Assay Development Market by Region [Analysis by Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Custom Assay Development Market

The market for developing specialized tests is constantly witnessing innovations, driven by technological advancements and an increasing need for customized diagnostic tools. The improvements in assay technology and a growing focus on personalized medicine are enabling the execution of better and more accurate tests in the healthcare and pharmaceutical industries. Here is a summary of recent developments in the United States, Chinese, German, Indian, and Japanese markets.

United States: The custom assay market is experiencing significant expansion due to advances in multiplex assays and the rise of rapid testing methods. Firms are strategically positioning themselves in the personalized medicine segment, leading to a growing number of requests for assay development. Collaborative research between biotech companies and universities is enhancing research capabilities and accelerating development.
China: There is increasing demand for custom assay development services in China, particularly in the fields of genomics and proteomics. Government investments in the health industry and biotechnology are fostering innovative development. Additionally, local companies are increasingly internationalizing the market by offering competitive rates and tailored solutions.
Germany: Germany is a leading country in Europe, capturing a substantial market share in custom assay services. High-throughput screening technologies are becoming more prevalent in assay development processes. The incorporation of automation and artificial intelligence in biostatistics and biotechnologies is enabling researchers to enhance the sophistication of assay design for drug discovery and diagnosis.
India: While a formal custom assay market is still emerging, India is currently experiencing a trend toward this sector due to rising demand for affordable diagnostic solutions. Advances in new technologies have empowered startups to produce cost-effective assays, particularly for infectious diseases. Collaborations with research organizations are further driving innovation in assay development.
Japan: Japan is making significant strides in the technological advancement of custom assay activities. Increasing partnerships between industry and academic/community institutions are facilitating the introduction of more advanced and specific assays, essential for precision medicine and targeted therapy approaches.

Features of the Global Custom Assay Development Market

Market Size Estimates: Custom assay development market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Custom assay development market size by type, application, and region in terms of value ($B).

Regional Analysis: Custom assay development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the custom assay development market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the custom assay development market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the custom assay development market by type (assay development, assay optimization, assay conversion, new analyte development, custom coupling, custom conjugation, sample testing, and others), application (medicine, biology, environment, academic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

1. Executive Summary

2. Global Custom Assay Development Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Custom Assay Development Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Custom Assay Development Market by Type
- 3.3.1: Assay Development
- 3.3.2: Assay Optimization
- 3.3.3: Assay Conversion
- 3.3.4: New Analyte Development
- 3.3.5: Custom Coupling
- 3.3.6: Custom Conjugation
- 3.3.7: Sample Testing
- 3.3.8: Others
3.4: Global Custom Assay Development Market by Application
- 3.4.1: Medicine
- 3.4.2: Biology
- 3.4.3: Environment
- 3.4.4: Academic
- 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

4.1: Global Custom Assay Development Market by Region
4.2: North American Custom Assay Development Market
- 4.2.1: North American Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
- 4.2.2: North American Market by Application: Medicine, Biology, Environment, Academic, and Others
4.3: European Custom Assay Development Market
- 4.3.1: European Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
- 4.3.2: European Market by Application: Medicine, Biology, Environment, Academic, and Others
4.4: APAC Custom Assay Development Market
- 4.4.1: APAC Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
- 4.4.2: APAC Market by Application: Medicine, Biology, Environment, Academic, and Others
4.5: ROW Custom Assay Development Market
- 4.5.1: ROW Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
- 4.5.2: ROW Market by Application: Medicine, Biology, Environment, Academic, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Custom Assay Development Market by Type
- 6.1.2: Growth Opportunities for the Global Custom Assay Development Market by Application
- 6.1.3: Growth Opportunities for the Global Custom Assay Development Market by Region
6.2: Emerging Trends in the Global Custom Assay Development Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Custom Assay Development Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Custom Assay Development Market
- 6.3.4: Certification and Licensing